Sophie D. Fosså

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

Anders Widmark, Olbjørn Klepp, Arne Solberg et al. · The Lancet · 2008 · 863 citations · Full text

Endocrine Oncology, Urology, Radiation Medicine +8

Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors

Lois B. Travis, Sophie D. Fosså, Sara J. Schonfeld et al. · JNCI Journal of the National Cancer Institute · 2005 · 827 citations · Full text

Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924

Cora N. Sternberg, P.H.M. de Mulder, Jan H. Schornagel et al. · Journal of Clinical Oncology · 2001 · 624 citations

Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours

Cora N. Sternberg, PHM de Mulder, Jan H. Schornagel et al. · European Journal of Cancer · 2005 · 542 citations

Year Update, Urology, Surgical Oncology +5

Cause-Specific Survival for Women Diagnosed With Cancer During Pregnancy or Lactation: A Registry-Based Cohort Study

Hanne Stensheim, Bjørn Møller, Tini van Dijk et al. · Journal of Clinical Oncology · 2008 · 509 citations · Full text